Coronavirus: AstraZeneca CEO hits back at ‘aggravated’ and ‘emotional’ EU
Pharmaceutical boss denies claim doses have been sold to higher bidder
AstraZeneca CEO Pascal Soriot has defended his company’s rollout of the Oxford Covid vaccine in the EU, describing its member states as “aggravated” and “emotional”.
After European leaders reacted with outrage at news that vaccine doses would be delayed, European Health Commissioner Stella Kyriakides said on Monday it was “not acceptable”, with Italy and Latvia threatening to sue the drugmaker.
Speaking to Italian newspaper La Repubblica, Soriot said the number that will be delivered is “not so bad”, adding that AstraZeneca only committed to meet demand to its “best effort”.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Soriot also rejected the suggestions that his company had diverted doses meant for the EU to higher bidders, insisting “we make no profit everywhere” under the agreement signed with Oxford University.
“We’re certainly not taking vaccines away from the Europeans to sell it somewhere else at the profit,” he said. “It would not make sense.”
The interview also included two boosts for Boris Johnson, with the first coming when Soriot “rejected calls to divert doses to the European Union following a breakdown in supply”, The Guardian says.
“The UK agreement was reached in June, three months before the European one,” he told La Repubblica. “As you could imagine, the UK government said the supply coming out of the UK supply chain would go for the UK first. Basically, that’s how it is.”
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Soriot also gave his backing to the government’s strategy of delaying the second vaccine in order to get the first dose to people more quickly. “I think the UK one-dose strategy is absolutely the right way to go, at least for our vaccine,” he said.
“First of all, we believe that the efficacy of one dose is sufficient: 100% protection against severe disease and hospitalisation, and 71-73% of efficacy overall. The second dose is needed for long term protection. But you get a better efficiency if you get the second dose later than earlier.”
Chas Newkey-Burden has been part of The Week Digital team for more than a decade and a journalist for 25 years, starting out on the irreverent football weekly 90 Minutes, before moving to lifestyle magazines Loaded and Attitude. He was a columnist for The Big Issue and landed a world exclusive with David Beckham that became the weekly magazine’s bestselling issue. He now writes regularly for The Guardian, The Telegraph, The Independent, Metro, FourFourTwo and the i new site. He is also the author of a number of non-fiction books.
-
Why Bhutan hopes tourists will put a smile back on its face
Under The Radar The 'kingdom of happiness' is facing economic problems and unprecedented emigration
By Chas Newkey-Burden, The Week UK Published
-
7 beautiful towns to visit in Switzerland during the holidays
The Week Recommends Find bliss in these charming Swiss locales that blend the traditional with the modern
By Catherine Garcia, The Week US Published
-
The Week contest: Werewolf bill
Puzzles and Quizzes
By The Week US Published
-
John Prescott: was he Labour's last link to the working class?
Today's Big Quesiton 'A total one-off': tributes have poured in for the former deputy PM and trade unionist
By Harriet Marsden, The Week UK Published
-
Last hopes for justice for UK's nuclear test veterans
Under the Radar Thousands of ex-service personnel say their lives have been blighted by aggressive cancers and genetic mutations
By Sorcha Bradley, The Week UK Published
-
Will Donald Trump wreck the Brexit deal?
Today's Big Question President-elect's victory could help UK's reset with the EU, but a free-trade agreement with the US to dodge his threatened tariffs could hinder it
By Harriet Marsden, The Week UK Published
-
What is the next Tory leader up against?
Today's Big Question Kemi Badenoch or Robert Jenrick will have to unify warring factions and win back disillusioned voters – without alienating the centre ground
By Harriet Marsden, The Week UK Published
-
What is Lammy hoping to achieve in China?
Today's Big Question Foreign secretary heads to Beijing as Labour seeks cooperation on global challenges and courts opportunities for trade and investment
By Harriet Marsden, The Week UK Published
-
Bob Woodward's War: the explosive Trump revelations
In the spotlight Nobody can beat Watergate veteran at 'getting the story of the White House from the inside'
By Chas Newkey-Burden, The Week UK Published
-
Trump kept up with Putin, sent Covid tests, book says
Speed Read The revelation comes courtesy of a new book by Bob Woodward
By Peter Weber, The Week US Published
-
'The federal government's response to the latest surge has been tepid at best'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published